share_log

Cimpress Plc Just Beat EPS By 73%: Here's What Analysts Think Will Happen Next

シンプレスがEPSを73%超えて打ち負かしました。アナリストたちは次に何が起こるか考えています。

Simply Wall St ·  02/02 07:40

Cimpress plc (NASDAQ:CMPR) defied analyst predictions to release its quarterly results, which were ahead of market expectations. The company beat forecasts, with revenue of US$921m, some 3.3% above estimates, and statutory earnings per share (EPS) coming in at US$2.14, 73% ahead of expectations. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.

earnings-and-revenue-growth
NasdaqGS:CMPR Earnings and Revenue Growth February 2nd 2024

Following the latest results, Cimpress' twin analysts are now forecasting revenues of US$3.30b in 2024. This would be a satisfactory 2.8% improvement in revenue compared to the last 12 months. Statutory earnings per share are predicted to shoot up 110% to US$3.32. Before this earnings report, the analysts had been forecasting revenues of US$3.28b and earnings per share (EPS) of US$2.84 in 2024. Although the revenue estimates have not really changed, we can see there's been a solid gain to earnings per share expectations, suggesting that the analysts have become more bullish after the latest result.

The analysts have been lifting their price targets on the back of the earnings upgrade, with the consensus price target rising 11% to US$105.

Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. It's clear from the latest estimates that Cimpress' rate of growth is expected to accelerate meaningfully, with the forecast 5.7% annualised revenue growth to the end of 2024 noticeably faster than its historical growth of 3.5% p.a. over the past five years. Compare this with other companies in the same industry, which are forecast to grow their revenue 6.7% annually. Factoring in the forecast acceleration in revenue, it's pretty clear that Cimpress is expected to grow at about the same rate as the wider industry.

The Bottom Line

The most important thing here is that the analysts upgraded their earnings per share estimates, suggesting that there has been a clear increase in optimism towards Cimpress following these results. They also reconfirmed their revenue estimates, with the company predicted to grow at about the same rate as the wider industry. There was also a nice increase in the price target, with the analysts clearly feeling that the intrinsic value of the business is improving.

With that in mind, we wouldn't be too quick to come to a conclusion on Cimpress. Long-term earnings power is much more important than next year's profits. We have analyst estimates for Cimpress going out as far as 2026, and you can see them free on our platform here.

You still need to take note of risks, for example - Cimpress has 3 warning signs (and 1 which is a bit concerning) we think you should know about.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする